Global Drugs Produced by Fermentation Engineering 麻豆原创 Research Report 2024

Publication ID:

PB507243238

Publication Date:

July 11, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Fermentation is a process used for cultivating micro-organisms or other organic material into important drugs such as antibiotics, therapeutic proteins, enzymes and insulin. It is typically carried out in temperature-controlled tanks (fermenter) which require addition of nutrients at the correct concentration to maximize productivity of the organism of interest.
The global Drugs Produced by Fermentation Engineering market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
In China, 5 largest manufacturers of Fermentation Engineering for Pharmaceutical Drugs are Changchun GeneScience Pharmaceutical, 3SBio Inc, Shanghai Fosun Pharmaceutical, Sichuan Kelun Pharmaceutical and Shanghai Shyndec Pharmaceutical, which make up over 15%. Among them, Changchun GeneScience Pharmaceutical is the leader with about 6% market share. In terms of product type, Monoclonal Antibodies occupy the largest share of the total market, about 54%. And in terms of product Application, the largest application is Hospital, followed by Clinic.
This report aims to provide a comprehensive presentation of the global market for Drugs Produced by Fermentation Engineering, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs Produced by Fermentation Engineering.
The Drugs Produced by Fermentation Engineering market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs Produced by Fermentation Engineering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs Produced by Fermentation Engineering companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group
Segment by Type
Monoclonal Antibodies
Antibiotic
Insulin
Human Growth Hormone
Pharmaceutical Amino Acids
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs Produced by Fermentation Engineering company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Drugs Produced by Fermentation Engineering 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Antibiotic
1.2.4 Insulin
1.2.5 Human Growth Hormone
1.2.6 Pharmaceutical Amino Acids
1.2.7 Others
1.3 麻豆原创 by Application
1.3.1 Global Drugs Produced by Fermentation Engineering 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs Produced by Fermentation Engineering 麻豆原创 Perspective (2019-2030)
2.2 Global Drugs Produced by Fermentation Engineering Growth Trends by Region
2.2.1 Global Drugs Produced by Fermentation Engineering 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drugs Produced by Fermentation Engineering Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Drugs Produced by Fermentation Engineering Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Drugs Produced by Fermentation Engineering 麻豆原创 Dynamics
2.3.1 Drugs Produced by Fermentation Engineering Industry Trends
2.3.2 Drugs Produced by Fermentation Engineering 麻豆原创 Drivers
2.3.3 Drugs Produced by Fermentation Engineering 麻豆原创 Challenges
2.3.4 Drugs Produced by Fermentation Engineering 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs Produced by Fermentation Engineering Players by Revenue
3.1.1 Global Top Drugs Produced by Fermentation Engineering Players by Revenue (2019-2024)
3.1.2 Global Drugs Produced by Fermentation Engineering Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Drugs Produced by Fermentation Engineering 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drugs Produced by Fermentation Engineering Revenue
3.4 Global Drugs Produced by Fermentation Engineering 麻豆原创 Concentration Ratio
3.4.1 Global Drugs Produced by Fermentation Engineering 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs Produced by Fermentation Engineering Revenue in 2023
3.5 Global Key Players of Drugs Produced by Fermentation Engineering Head office and Area Served
3.6 Global Key Players of Drugs Produced by Fermentation Engineering, Product and Application
3.7 Global Key Players of Drugs Produced by Fermentation Engineering, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs Produced by Fermentation Engineering Breakdown Data by Type
4.1 Global Drugs Produced by Fermentation Engineering Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Drugs Produced by Fermentation Engineering Forecasted 麻豆原创 Size by Type (2025-2030)
5 Drugs Produced by Fermentation Engineering Breakdown Data by Application
5.1 Global Drugs Produced by Fermentation Engineering Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Drugs Produced by Fermentation Engineering Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Drugs Produced by Fermentation Engineering 麻豆原创 Size (2019-2030)
6.2 North America Drugs Produced by Fermentation Engineering 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drugs Produced by Fermentation Engineering 麻豆原创 Size by Country (2019-2024)
6.4 North America Drugs Produced by Fermentation Engineering 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs Produced by Fermentation Engineering 麻豆原创 Size (2019-2030)
7.2 Europe Drugs Produced by Fermentation Engineering 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drugs Produced by Fermentation Engineering 麻豆原创 Size by Country (2019-2024)
7.4 Europe Drugs Produced by Fermentation Engineering 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs Produced by Fermentation Engineering 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Drugs Produced by Fermentation Engineering 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drugs Produced by Fermentation Engineering 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Drugs Produced by Fermentation Engineering 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs Produced by Fermentation Engineering 麻豆原创 Size (2019-2030)
9.2 Latin America Drugs Produced by Fermentation Engineering 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drugs Produced by Fermentation Engineering 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Drugs Produced by Fermentation Engineering 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs Produced by Fermentation Engineering 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Drugs Produced by Fermentation Engineering 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drugs Produced by Fermentation Engineering 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Drugs Produced by Fermentation Engineering 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Changchun GeneScience Pharmaceutical
11.1.1 Changchun GeneScience Pharmaceutical Company Details
11.1.2 Changchun GeneScience Pharmaceutical Business Overview
11.1.3 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Introduction
11.1.4 Changchun GeneScience Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.1.5 Changchun GeneScience Pharmaceutical Recent Development
11.2 3SBio Inc
11.2.1 3SBio Inc Company Details
11.2.2 3SBio Inc Business Overview
11.2.3 3SBio Inc Drugs Produced by Fermentation Engineering Introduction
11.2.4 3SBio Inc Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.2.5 3SBio Inc Recent Development
11.3 Shanghai Fosun Pharmaceutical
11.3.1 Shanghai Fosun Pharmaceutical Company Details
11.3.2 Shanghai Fosun Pharmaceutical Business Overview
11.3.3 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Introduction
11.3.4 Shanghai Fosun Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.3.5 Shanghai Fosun Pharmaceutical Recent Development
11.4 Sichuan Kelun Pharmaceutical
11.4.1 Sichuan Kelun Pharmaceutical Company Details
11.4.2 Sichuan Kelun Pharmaceutical Business Overview
11.4.3 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Introduction
11.4.4 Sichuan Kelun Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.4.5 Sichuan Kelun Pharmaceutical Recent Development
11.5 Shanghai Shyndec Pharmaceutical
11.5.1 Shanghai Shyndec Pharmaceutical Company Details
11.5.2 Shanghai Shyndec Pharmaceutical Business Overview
11.5.3 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Introduction
11.5.4 Shanghai Shyndec Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.5.5 Shanghai Shyndec Pharmaceutical Recent Development
11.6 CSPC Pharmaceutical Group
11.6.1 CSPC Pharmaceutical Group Company Details
11.6.2 CSPC Pharmaceutical Group Business Overview
11.6.3 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Introduction
11.6.4 CSPC Pharmaceutical Group Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.6.5 CSPC Pharmaceutical Group Recent Development
11.7 United Laboratories International Holdings
11.7.1 United Laboratories International Holdings Company Details
11.7.2 United Laboratories International Holdings Business Overview
11.7.3 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Introduction
11.7.4 United Laboratories International Holdings Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.7.5 United Laboratories International Holdings Recent Development
11.8 Tonghua Dongbao Pharmaceutical
11.8.1 Tonghua Dongbao Pharmaceutical Company Details
11.8.2 Tonghua Dongbao Pharmaceutical Business Overview
11.8.3 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Introduction
11.8.4 Tonghua Dongbao Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.8.5 Tonghua Dongbao Pharmaceutical Recent Development
11.9 Joincare Pharmaceutical Group
11.9.1 Joincare Pharmaceutical Group Company Details
11.9.2 Joincare Pharmaceutical Group Business Overview
11.9.3 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Introduction
11.9.4 Joincare Pharmaceutical Group Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.9.5 Joincare Pharmaceutical Group Recent Development
11.10 North China Pharma
11.10.1 North China Pharma Company Details
11.10.2 North China Pharma Business Overview
11.10.3 North China Pharma Drugs Produced by Fermentation Engineering Introduction
11.10.4 North China Pharma Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.10.5 North China Pharma Recent Development
11.11 Anhui Anke Biotechnology
11.11.1 Anhui Anke Biotechnology Company Details
11.11.2 Anhui Anke Biotechnology Business Overview
11.11.3 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Introduction
11.11.4 Anhui Anke Biotechnology Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.11.5 Anhui Anke Biotechnology Recent Development
11.12 Gan and Lee Pharmaceuticals
11.12.1 Gan and Lee Pharmaceuticals Company Details
11.12.2 Gan and Lee Pharmaceuticals Business Overview
11.12.3 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Introduction
11.12.4 Gan and Lee Pharmaceuticals Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.12.5 Gan and Lee Pharmaceuticals Recent Development
11.13 Shandong Kexing Bioproducts
11.13.1 Shandong Kexing Bioproducts Company Details
11.13.2 Shandong Kexing Bioproducts Business Overview
11.13.3 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Introduction
11.13.4 Shandong Kexing Bioproducts Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.13.5 Shandong Kexing Bioproducts Recent Development
11.14 Harbin Pharmaceutical Group
11.14.1 Harbin Pharmaceutical Group Company Details
11.14.2 Harbin Pharmaceutical Group Business Overview
11.14.3 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Introduction
11.14.4 Harbin Pharmaceutical Group Revenue in Drugs Produced by Fermentation Engineering Business (2019-2024)
11.14.5 Harbin Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.